Pfizer COVID vaccine clears Japan panel for use with young children

Reuters

TOKYO (Reuters) -A Japanese health ministry panel on Wednesday recommended approving Pfizer Inc’s COVID-19 vaccine for children as young as six months old.

Japan in January expanded use of the vaccine to those as young as five years old. Last month, health authorities started to dispensing Pfizer and Moderna Inc booster shots that target the Omicron variant of the virus.

The panel also recommended approval of a version of the Pfizer vaccine that protects against the BA.4 and BA.5 subvariants of Omicron. Moderna said earlier on Wednesday it was seeking Japanese approval of its own subvariant shot.

Related News:   Across US, homeless initiatives highlight a growing crisis

(Reporting by Rocky Swift and Kantaro Komiya, Editing by Louise Heavens)


tagreuters.com2022binary_LYNXMPEI940J6-BASEIMAGE

You appear to be using an ad blocker

Shore News Network is a free website that does not use paywalls or charge for access to original, breaking news content. In order to provide this free service, we rely on advertisements. Please support our journalism by disabling your ad blocker for this website.